Virtual Reality-Augmented Future Orientation in Stimulant Use Disorder Recovery
虚拟现实增强兴奋剂使用障碍康复的未来方向
基本信息
- 批准号:10455193
- 负责人:
- 金额:$ 23.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAftercareAgeAttentionBehaviorBehavior TherapyBehavioralBehavioral MechanismsBiometryBrainClinical PsychologyClinical TrialsCommunitiesDataDecision MakingDevelopmentDrug usageEffectivenessEmotionalEventEvidence based interventionExhibitsFrequenciesFutureGoalsImmersionImpairmentIndividualInterventionInterviewIntoxicationInvestmentsItalyLaboratoriesMethodsMotivationNeuropsychological TestsOutcomeParticipantPatient Self-ReportPatientsPersonsPharmacotherapyPreparationRandomized Clinical TrialsRandomized Controlled TrialsRecoveryRelapseResistanceRewardsSamplingSensorySignal TransductionStimulantSubstance Use DisorderSubstance abuse problemTestingThinkingTimeTravelTreatment outcomeValidationVirtual and Augmented realityWorkbehavior changebehavior testbehavioral economicscravingdesigndigitaldiscountingdisorder later incidence preventiondrug abstinencedrug efficacydrug testingefficacy testingefficacy trialendophenotypeexperiencefeasibility testingfollow-uphedonicimprovedmalemedication-assisted treatmentmultidisciplinaryneglectnon-drugnovelopen labeloptimismpersonalized medicineprecision medicinepreferencerecruitrelapse riskresponsesafety and feasibilitystimulant abusestimulant usestimulant use disordersuccesssuccessful interventiontheoriestreatment as usualvirtualvirtual realityvirtual reality environmentvirtual reality interventionvirtual world
项目摘要
PROJECT SUMMARY / ABSTRACT
We propose a novel virtual reality intervention to test for efficacy on reducing stimulant use and increasing
abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-
reward, in early recovering stimulant use disorder (StUD) persons. Impaired future orientation and delay-of-
reward appear to be behavioral endophenotypes for substance use disorders. With recovery attempts usually
failing within 6 months of treatment, there is considerable room for improved efficacy. Converging evidence
indicates that a hallmark of StUD is impaired visualizing and planning for the future, which corresponds to
greater devaluation of delayed rewards. Our preliminary tests of the intervention were promising, with n=14 out
of n=18 participants remaining abstinent 30 days later; importantly, 10 of the 14 abstainers showed a positive
response to the intervention, suggesting an efficacy marker. The intervention increases future self-identification
and delay-of-reward in people recovering from substance use disorder, and engages brain networks governing
prospection; further, the VR effect on delay-of-reward correlated with introspective-executive brain connectivity.
Extending prior work on episodic future thinking, we employed a precision medicine approach in designing a
personalized immersive virtual experience that integrates personal details and maximizes sensory
engagement. Our intervention increases connectedness with one’s future by immersing subjects in a realistic
portrayal of interacting with their Future Selves in divergent futures. Importantly, we integrate self-discrepancy
theory, focusing on the gap between “what is” and “what could be” to heighten motivation, and we promote
engagement by maximizing the novelty and emotional salience of the experience. Early-recovering StUD
persons enter a realistic virtual world, are introduced to a time travel narrative, and interact with two digitally
age-progressed Future Selves; one after 15 years of ongoing stimulant abuse, and the other after 15 years of
recovery. Both Future Selves speak to the participant about their recovery rewards, or losses from returning to
habitual drug use, and personal struggles during the journey. Strong emphasis is placed on agency, optimism,
and decision-making. After iterative development and tests of feasibility and safety, the paradigm yielded a
promising efficacy signal, behavioral change, and brain target engagement. The current proposal will validate
this paradigm in an expanded sample to show efficacy and behavioral mechanisms using the same VR
paradigm. Aim 1 will test for efficacy on stimulant and drug use outcomes (amount, frequency, type, relapse,
and abstinence) with longitudinal assessments at 1 and 6 months. Aim 2 will determine mechanisms by testing
for changes in future self-identification, future time perspective, and behavioral delay discounting. The long-
term goal of the project is to validate a potent adjunctive intervention with long-term recovery benefits that is
readily implemented during post-treatment aftercare or in a treatment setting.
项目概要/摘要
我们提出了一种新颖的虚拟现实干预措施,以测试减少兴奋剂使用和增加兴奋剂使用的功效。
禁欲,伴随着未来自我认同、未来时间洞察力和延迟的增加
奖励,在早期恢复兴奋剂使用障碍(StUD)的人中受损的未来方向和延迟。
奖励似乎是物质使用障碍的行为内表型,通常与恢复尝试有关。
如果在治疗后 6 个月内失败,则有相当大的证据表明疗效有改善的空间。
表明StUD的一个特点是对未来的可视化和规划受损,这对应于
我们对干预措施的初步测试是有希望的,n=14。
重要的是,n = 18 名参与者在 30 天后仍然禁欲,14 名禁欲者中有 10 人表现出阳性;
对干预的反应,表明干预增加了未来的自我认同。
以及从物质使用障碍中恢复的人们的延迟奖励,并参与管理大脑网络
此外,VR 对延迟奖励的影响与内省执行大脑的连通性相关。
扩展了之前关于情景未来思维的工作,我们采用了精准医学方法来设计
融合个人细节、最大化感官的个性化沉浸式虚拟体验
我们的干预通过让受试者沉浸在现实中来增加与未来的联系。
在不同的未来中与未来的自己互动的描绘。重要的是,我们整合了自我差异。
理论,关注“是什么”和“可能是什么”之间的差距,以提高动力,我们提倡
通过最大化体验的新颖性和情感显着性来提高参与度。
人们进入一个现实的虚拟世界,被引入时间旅行叙事,并与两个数字互动
随着年龄的增长,未来的自己;一个是持续滥用兴奋剂 15 年之后,另一个是持续滥用兴奋剂 15 年之后
两个未来的自己都会向参与者讲述他们的恢复奖励或返回的损失。
习惯性吸毒以及旅途中的个人挣扎非常强调代理、乐观、
经过迭代开发以及可行性和安全性测试后,该范式产生了一个
有前景的功效信号、行为改变和大脑目标参与将得到验证。
该范式在扩展样本中展示使用相同 VR 的功效和行为机制
目标 1 将测试兴奋剂和药物使用结果的功效(数量、频率、类型、复发、
和禁欲),并在 1 个月和 6 个月进行纵向评估,目标 2 将通过测试确定机制。
未来自我认同、未来时间视角和行为延迟贴现的变化。
该项目的长期目标是验证具有长期恢复益处的有效辅助干预措施,即
可以在治疗后护理期间或在治疗环境中轻松实施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brandon Oberlin其他文献
Brandon Oberlin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brandon Oberlin', 18)}}的其他基金
High-intensity and Sensation Seeking Associations with Episodic Simulation Efficacy and Brain Response
高强度和感觉寻求与情景模拟功效和大脑反应的关联
- 批准号:
10670821 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
Enhancing Prospection with Virtual Reality in Alcohol Use Disorder Recovery
通过虚拟现实增强酒精使用障碍康复的前景
- 批准号:
10687816 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
High-intensity and Sensation Seeking Associations with Episodic Simulation Efficacy and Brain Response
高强度和感觉寻求与情景模拟功效和大脑反应的关联
- 批准号:
10452210 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
Enhancing Prospection with Virtual Reality in Alcohol Use Disorder Recovery
通过虚拟现实增强酒精使用障碍康复的前景
- 批准号:
10444167 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
Virtual Reality-Augmented Future Orientation in Stimulant Use Disorder Recovery
虚拟现实增强兴奋剂使用障碍康复的未来方向
- 批准号:
10611503 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
Assessing Impulsivity in High Alcohol Preferring Mice
评估高酒精偏好小鼠的冲动性
- 批准号:
7315390 - 财政年份:2006
- 资助金额:
$ 23.78万 - 项目类别:
Assessing Impulsivity in High Alcohol Preferring Mice
评估高酒精偏好小鼠的冲动性
- 批准号:
7876972 - 财政年份:2006
- 资助金额:
$ 23.78万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
- 批准号:
10546293 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness
双烟夫妇二元经济激励治疗的随机对照试验:疗效、机制和成本效益评估
- 批准号:
10734422 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Modular Virtual Reality Therapeutic for Opioid and Stimulant Use Disorders
针对阿片类药物和兴奋剂使用障碍的模块化虚拟现实治疗
- 批准号:
10784642 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别: